Randomized controlled trial outcome indicators of traditional Chinese medicine for gastrointestinal dysfunction in sepsis in recent two years / 中国中药杂志

The purpose of the study is to analyze the outcomes of randomized controlled trial(RCT) of Chinese herbal medicine formula(CHMF) in the treatment of gastrointestinal dysfunction in sepsis in recent two years. We systematically searched four Chinese databases, three English databases, and two clinical trial registries to analyze the reports of outcome indicators of clinical trials, and evaluated the risk of bias by using the ROB tool of Cochrane Collaboration. After screening, 55 clinical RCTs were included. The results showed that the current clinical studies of gastrointestinal dysfunction in sepsis reported the efficacy and safety indicators. The efficacy indicators included APACHE Ⅱ scores, gastrointestinal dysfunction scores, bowel sound scores, and inflammatory indicator such as C-reactive protein and procalcitonin. The safety indicators mainly include gastrointestinal reactions, skin reactions, and other adverse events and adverse reactions. However, there was no distinction between primary and secondary outcomes. The relevant indicators of health economics were not reported, and the quality of research methodology was poor. Therefore, we suggest that future researchers should be well prepared in the top-level design stage and actively construct the core outcome set, so as to improve the quality of clinical trials.

Research Progress on Non-Drug Treatment for Blood Glucose Control of Type 2 Diabetes Mellitus / 中国结合医学杂志

Type 2 diabetes mellitus (T2DM) is one of the common endocrinology diseases that greatly affects the health care sector and economy. Application of hypoglycemic drugs has its own drawbacks and the use of non-drug therapy on treating T2DM has drawn much attention recently. This paper reviewed the research development of the non-pharmacological interventions on T2DM in recent years, including dietary therapy, exercise therapy, psychotherapy, acupuncture and moxibustion therapies and so on. The authors mentioned the problems in the research of non-drug treatment for blood glucose control of T2DM and put forward new ideas for the research in the future. Further well-designed trials with large sample size and long-term follow-up are needed to confirm current conclusions.

Treatment of calcium dobesilate tablets capsules combined yimaikang for retinal vein occlusion / 国际眼科杂志(Guoji Yanke Zazhi)

AlM: To observe the clinical curative effect of calcium dobesilate capsule and yimaikang tablet for treating retinal vein occlusion ( RVO) .METHODS:A total of 120 patients (167 eyes) with RVO were divided into 2 groups at random. The control group of 60 cases ( 82 eyes ) were given calcium dobesilate capsule, and the treatment group of 60 cases ( 85 eyes ) received calcium dobesilate capsule and yimaikang tablet. Changes of visual acuity and clinical effects after 3 courses of treatment were compared and analyzed for all patients.RESULTS: Markedly effective 15 cases ( 23 eyes ) , effective 42 cases (57 eyes) and invalid 3 cases (5 eyes) in the 60 cases (85 eyes) of the treatment group, the total effective rate was 94. 1%. Eighty-two eyes of 60 cases in the control group, markedly effective in 8 cases ( 12 eyes), effective 38 cases (49 eyes), ineffective 14 cases (21 eyes), The total effective rate was 74. 4% in the control group. There were significant differences between the 2 groups of curative effect, and low incidence rate of adverse reaction. CONCLUSlON: Calcium dobesilate capsules and yimaikang tablet is effective and safe in the treatment of RVO.